Adult stem cells: Phase II start

Mesoblast said in its earnings for 1H13 ended Dec. 31, 2012, that in May it plans to begin a double-blind, placebo-controlled, dose-escalation Phase II trial comparing single IV infusions of 1 and 2 m...